Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ: EVO )

5.230 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.230
Bid (Size) 5.180 (3)
Ask (Size) 5.200 (2)
Prev. Close 5.230
Today's Range 5.230 - 5.230
52wk Range 5.000 - 13.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Crude Oil Moves Lower; B. Riley Financial Shares Jump
Via Benzinga
Exposures Fossil Fuels
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga

Performance

YTD
-54.12%
-54.12%
1 Month
-28.55%
-28.55%
3 Month
-35.99%
-35.99%
6 Month
-39.82%
-39.82%
1 Year
-43.09%
-43.09%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Evotec SE: Invitation to Conference Call
Via ACCESSWIRE
Dow Dips Over 100 Points; Ribbon Communications Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Rises 0.5%; Tesla Shares Jump After Q1 Results
Via Benzinga
Life Science-Focused Evotec Shares Plunge To 6 Year Lows On Gloomy Annual Forecast
Via Benzinga
Why Is Fabrinet (FN) Stock Down Today?
Via InvestorPlace
Why Is Evotec (EVO) Stock Down 33% Today?
Via InvestorPlace
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Enphase Energy Reports Weak Results, Joins Lithia Motors And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth
Via ACCESSWIRE
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
Via ACCESSWIRE
Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
Via ACCESSWIRE
Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
Via ACCESSWIRE
Evotec welcomes Aurélie Dalbiez as Chief People Officer
Via ACCESSWIRE
Finding the Next Big Winners: 7 Stocks You Can Snag for Under $10
Via InvestorPlace
3 Stocks Set to Double: Your Fast Track to 2024 Gains
Via InvestorPlace
Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic
Via ACCESSWIRE
7 Stable Stocks to Buy for 100% Returns by 2025
Via InvestorPlace
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
Via InvestorPlace
Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV
Via ACCESSWIRE
What's Going On With Life Science Company Evotec Stock Today?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.